Top Markets
#1 ADO Protocol ADO Protocol +328.68%
#2 GoPlus Security GoPlus Security +51.28%
#3 Nockchain Nockchain +41.03%
#4 Starpower Starpower +35.74%
#5 The Black Bull The Black Bull +35.04%
#6 Verus Coin Verus Coin +33.47%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +33.42%
#8 Tutorial Tutorial +32.05%
#9 GAIB AID GAIB AID +24.67%
#10 Moolah Moolah +21.60%
Coin of the day
ADO Protocol ADO Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
Liminatus Pharma, Inc. Class A Common Stock Liminatus Pharma, Inc. Class A Common Stock

Liminatus Pharma, Inc. Class A Common Stock

LIMN
Rank in Stocks #32695
Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical... Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, California.
Share Price
$0.1407
Market Cap
$9.45M
Change (1 day)
0.50%
Change (1 year)
-96.48%
Country
US
Trade Liminatus Pharma, Inc. Class A Common Stock (LIMN)

Category

Healthcare
Earnings for Liminatus Pharma, Inc. Class A Common Stock (LIMN)
Earnings in 2026 TTM: 0
According to Liminatus Pharma, Inc. Class A Common Stock latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Liminatus Pharma, Inc. Class A Common Stock from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE